Skip to content
Trial Eligibility
Menu

Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord

NCT06225245

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to investigate the effects of cervical epidural spinal stimulation with upper extremity training. This is an investigational study. The device used for epidural spinal stimulation (ESS) to deliver spinal stimulation is called the CoverEdgeX 32 Surgical Lead system. This device is approved by the Food and Drug Administration (FDA) for the treatment of severe pain and to manage chronic pain when other treatments have not been effective.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Spinal Cord Injuries
  • Cervical Spinal Cord Injury

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
The Methodist Hospital Research Institute
Last updated on ClinicalTrials.gov
April 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • The Methodist Hospital Research Institute · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.